Target intelligence / Profile preview

Proteasome subunit alpha 6 pseudogene 3 (PSMA6P3)

Target
PSMA6P3
Molecular classification
Other (Pseudogene), Related to peptidase T1A family (by homology to parent gene PSMA6)
01

Overview

Proteasome subunit alpha 6 pseudogene 3 (PSMA6P3) is a human pseudogene annotated on chromosome 21 and does not encode a functional protein. It is homologous to the active proteasome subunit alpha type-6 (PSMA6), which is part of the 20S proteasome core complex responsible for regulated protein degradation in cells. As a pseudogene, PSMA6P3 may possess potential regulatory functions at the RNA level, such as acting as a competitive endogenous RNA ("miRNA decoy") that influences gene expression of related coding genes, a property demonstrated for other pseudogenes in cancer or disease biology. However, there is currently no direct evidence linking PSMA6P3 to such regulatory activity, nor to any disease or therapeutic relevance. PSMA6P3 is not a druggable target, does not encode a receptor or enzyme, and lacks known roles in human pathophysiology. In summary, PSMA6P3 is a pseudogene and should not be considered a receptor, enzyme, or direct therapeutic target. While related pseudogenes can have biological roles via non-coding RNA regulation, no such functions have been experimentally validated or widely accepted for PSMA6P3.

Other names
Proteasome (prosome, macropain) subunit, alpha type, 6 pseudogene 3PSMA6P3GC00U931971GC21M047492
02

Mechanism of action

None applicable (no known drugs or direct targeting mechanisms)

03

Biological functions

No protein function (as a pseudogene)May have possible regulatory effects via RNA mechanisms (see "description"), but does not participate directly in canonical proteasome activity
04

Disease associations

None established in literature for PSMA6P3 specificallyPseudogenes collectively have emerging roles in cancer and disease regulation via RNA-mediated functions, but there is no evidence for PSMA6P3-specific involvement

Beyond the preview

Go deeper on Proteasome subunit alpha 6 pseudogene 3 (PSMA6P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proteasome subunit alpha 6 pseudogene 3 (PSMA6P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call